The pump is FDA-approved for patients with right heart failure and allows the patient’s heart to rest and recover its ability to pump blood. It can be effective for patients who experience cardiogenic shock during acute myocardial infarction because 30 percent of shock patients experience bi-ventricular failure.
For more information, visit www.sanjuanregional.com.